Profile | GDS5420 / 1560476_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 88.63 | 40 |
GSM1296119 | B_lesional_pre-dose | 117.33 | 43 |
GSM1296076 | C_lesional_pre-dose | 72.76 | 37 |
GSM1296092 | D_lesional_pre-dose | 66.42 | 38 |
GSM1296103 | E_lesional_pre-dose | 32.81 | 25 |
GSM1296078 | F_lesional_pre-dose | 56.84 | 33 |
GSM1296107 | G_lesional_pre-dose | 129.16 | 44 |
GSM1296109 | H_lesional_pre-dose | 108.03 | 41 |
GSM1296080 | I_lesional_pre-dose | 45.76 | 31 |
GSM1296090 | J_lesional_pre-dose | 59.34 | 35 |
GSM1296074 | K_lesional_pre-dose | 89.46 | 42 |
GSM1296111 | L_lesional_pre-dose | 167.06 | 48 |
GSM1296099 | M_lesional_pre-dose | 31.37 | 24 |
GSM1296086 | O_lesional_pre-dose | 59.52 | 35 |
GSM1296117 | P_lesional_pre-dose | 251.35 | 55 |
GSM1296113 | Q_lesional_pre-dose | 384.04 | 63 |
GSM1296096 | R_lesional_pre-dose | 50.58 | 32 |
GSM1296105 | S_lesional_pre-dose | 55.47 | 32 |
GSM1296098 | T_lesional_pre-dose | 216.69 | 53 |
GSM1296101 | U_lesional_pre-dose | 63.6 | 34 |
GSM1296121 | V_lesional_pre-dose | 152.42 | 47 |
GSM1296088 | W_lesional_pre-dose | 59.01 | 34 |
GSM1296082 | X_lesional_pre-dose | 41.06 | 30 |
GSM1296115 | Y_lesional_pre-dose | 178.23 | 50 |
GSM1296084 | Z_lesional_pre-dose | 68.68 | 35 |
GSM1296072 | B_lesional_day8 | 115.95 | 42 |
GSM1296069 | L_lesional_day8 | 264.01 | 56 |
GSM1296071 | P_lesional_day8 | 241.34 | 54 |
GSM1296070 | Y_lesional_day8 | 222.86 | 53 |
GSM1296073 | V_lesional_day8 | 181.7 | 51 |
GSM1296034 | A_lesional_day15 | 58.42 | 32 |
GSM1296041 | G_lesional_day15 | 307.59 | 59 |
GSM1296035 | R_lesional_day15 | 50.33 | 33 |
GSM1296038 | U_lesional_day15 | 91.06 | 40 |
GSM1296047 | B_lesional_day15 | 165.78 | 48 |
GSM1296039 | E_lesional_day15 | 63.68 | 35 |
GSM1296042 | H_lesional_day15 | 188.38 | 50 |
GSM1296043 | L_lesional_day15 | 337.29 | 60 |
GSM1296037 | M_lesional_day15 | 81.57 | 37 |
GSM1296046 | P_lesional_day15 | 345.78 | 61 |
GSM1296044 | Q_lesional_day15 | 323.7 | 59 |
GSM1296045 | Y_lesional_day15 | 238.48 | 54 |
GSM1296025 | C_lesional_day15 | 80.03 | 38 |
GSM1296033 | D_lesional_day15 | 58.02 | 34 |
GSM1296027 | I_lesional_day15 | 51.01 | 34 |
GSM1296032 | J_lesional_day15 | 136.12 | 46 |
GSM1296024 | K_lesional_day15 | 67.17 | 36 |
GSM1296031 | W_lesional_day15 | 110.53 | 42 |
GSM1296028 | X_lesional_day15 | 67.47 | 36 |
GSM1296029 | Z_lesional_day15 | 100.23 | 42 |
GSM1296026 | F_lesional_day15 | 33.86 | 24 |
GSM1296030 | O_lesional_day15 | 28.56 | 26 |
GSM1296040 | S_lesional_day15 | 88.85 | 39 |
GSM1296036 | T_lesional_day15 | 105.62 | 41 |
GSM1296048 | V_lesional_day15 | 147.57 | 47 |
GSM1296059 | A_lesional_day43 | 36.16 | 27 |
GSM1296066 | G_lesional_day43 | 317.46 | 60 |
GSM1296060 | R_lesional_day43 | 67.76 | 36 |
GSM1296063 | U_lesional_day43 | 73.43 | 36 |
GSM1296064 | E_lesional_day43 | 138.7 | 47 |
GSM1296067 | H_lesional_day43 | 174.05 | 48 |
GSM1296062 | M_lesional_day43 | 57.34 | 33 |
GSM1296068 | Q_lesional_day43 | 375.42 | 62 |
GSM1296050 | C_lesional_day43 | 70.82 | 36 |
GSM1296057 | D_lesional_day43 | 38.53 | 28 |
GSM1296052 | I_lesional_day43 | 56.95 | 35 |
GSM1296054 | J_lesional_day43 | 66.43 | 34 |
GSM1296049 | K_lesional_day43 | 62.28 | 34 |
GSM1296055 | W_lesional_day43 | 72.39 | 35 |
GSM1296053 | X_lesional_day43 | 74.08 | 37 |
GSM1296058 | Z_lesional_day43 | 66.83 | 37 |
GSM1296051 | F_lesional_day43 | 53.86 | 32 |
GSM1296056 | O_lesional_day43 | 47.34 | 32 |
GSM1296065 | S_lesional_day43 | 36.27 | 26 |
GSM1296061 | T_lesional_day43 | 142.87 | 46 |
GSM1296095 | A_non-lesional_pre-dose | 72.09 | 37 |
GSM1296120 | B_non-lesional_pre-dose | 149.45 | 46 |
GSM1296077 | C_non-lesional_pre-dose | 37.63 | 27 |
GSM1296093 | D_non-lesional_pre-dose | 57.71 | 32 |
GSM1296104 | E_non-lesional_pre-dose | 80.7 | 38 |
GSM1296079 | F_non-lesional_pre-dose | 79.66 | 38 |
GSM1296108 | G_non-lesional_pre-dose | 233.63 | 54 |
GSM1296110 | H_non-lesional_pre-dose | 160.67 | 46 |
GSM1296081 | I_non-lesional_pre-dose | 48.58 | 33 |
GSM1296091 | J_non-lesional_pre-dose | 66.91 | 36 |
GSM1296075 | K_non-lesional_pre-dose | 168.21 | 51 |
GSM1296112 | L_non-lesional_pre-dose | 298.93 | 57 |
GSM1296100 | M_non-lesional_pre-dose | 49.04 | 30 |
GSM1296087 | O_non-lesional_pre-dose | 46.65 | 32 |
GSM1296118 | P_non-lesional_pre-dose | 266.55 | 56 |
GSM1296114 | Q_non-lesional_pre-dose | 403.67 | 63 |
GSM1296097 | R_non-lesional_pre-dose | 74.21 | 37 |
GSM1296106 | S_non-lesional_pre-dose | 56.39 | 31 |
GSM1296102 | U_non-lesional_pre-dose | 69.38 | 35 |
GSM1296122 | V_non-lesional_pre-dose | 138.5 | 45 |
GSM1296089 | W_non-lesional_pre-dose | 202.09 | 52 |
GSM1296083 | X_non-lesional_pre-dose | 39.48 | 28 |
GSM1296116 | Y_non-lesional_pre-dose | 342.85 | 60 |
GSM1296085 | Z_non-lesional_pre-dose | 102.16 | 42 |